How Can Toxicology Help in Developing Neuraminidase Inhibitors?
Toxicology plays a vital role in the development of neuraminidase inhibitors by evaluating the safety and efficacy of these compounds. This involves preclinical studies to assess toxicity, pharmacokinetics, and pharmacodynamics. Toxicologists also conduct clinical trials to monitor adverse effects and determine optimal dosing regimens. Additionally, post-marketing surveillance helps in identifying long-term safety concerns and ensuring the continued efficacy of these drugs.
